Y-Intercept (HK)’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-106,606	Closed	-$689K	–	1003
2023 Q2	$689K	Buy	+106,606	New	+$689K	0.07%	429
2022 Q2	–	Sell	-46,355	Closed	-$452K	–	828
2022 Q1	$452K	Buy	+46,355	New	+$452K	0.1%	293